LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Normalized Growth Rate Inhibition Value | Standard Error of the Mean for Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | HG-5-88-01 | 0.04 | uM | LJP6 | 0.7206 | 0.0194 | 0.5477 | 0.0738 |
| SK-BR-3 | HG-5-88-01 | 0.12 | uM | LJP6 | 0.8084 | 0.0184 | 0.6910 | 0.0602 |
| SK-BR-3 | HG-5-88-01 | 0.37 | uM | LJP6 | 0.7977 | 0.0078 | 0.6777 | 0.0423 |
| SK-BR-3 | HG-5-88-01 | 1.11 | uM | LJP6 | 0.8115 | 0.0156 | 0.6990 | 0.0461 |
| SK-BR-3 | HG-5-88-01 | 3.33 | uM | LJP6 | 0.7806 | 0.0457 | 0.6407 | 0.0965 |
| SK-BR-3 | HG-5-88-01 | 10 | uM | LJP6 | 0.4790 | 0.0124 | 0.1328 | 0.0874 |
| SK-BR-3 | HG-6-64-01 | 0.04 | uM | LJP6 | 1.1159 | 0.0170 | 1.1840 | 0.0424 |
| SK-BR-3 | HG-6-64-01 | 0.12 | uM | LJP6 | 0.9880 | 0.0735 | 1.0035 | 0.1107 |
| SK-BR-3 | HG-6-64-01 | 0.37 | uM | LJP6 | 0.8924 | 0.0558 | 0.8472 | 0.0739 |
| SK-BR-3 | HG-6-64-01 | 1.11 | uM | LJP6 | 0.7789 | 0.0187 | 0.6546 | 0.0098 |
| SK-BR-3 | HG-6-64-01 | 3.33 | uM | LJP6 | 0.5702 | 0.0211 | 0.3010 | 0.0260 |
| SK-BR-3 | HG-6-64-01 | 10 | uM | LJP6 | 0.1866 | 0.0315 | -0.4531 | 0.0432 |
| SK-BR-3 | Neratinib | 0.04 | uM | LJP5 | 0.3342 | 0.0259 | -0.1081 | 0.1102 |
| SK-BR-3 | Neratinib | 0.12 | uM | LJP5 | 0.3312 | 0.0293 | -0.1137 | 0.1150 |
| SK-BR-3 | Neratinib | 0.37 | uM | LJP5 | 0.3174 | 0.0274 | -0.1404 | 0.1091 |
| SK-BR-3 | Neratinib | 1.11 | uM | LJP5 | 0.3297 | 0.0382 | -0.1175 | 0.1281 |
| SK-BR-3 | Neratinib | 3.33 | uM | LJP5 | 0.3119 | 0.0351 | -0.1524 | 0.1251 |
| SK-BR-3 | Neratinib | 10 | uM | LJP5 | 0.2801 | 0.0233 | -0.2154 | 0.1107 |
| SK-BR-3 | JW-7-24-1 | 0.04 | uM | LJP6 | 0.7568 | 0.0126 | 0.6153 | 0.0194 |
| SK-BR-3 | JW-7-24-1 | 0.12 | uM | LJP6 | 0.8066 | 0.0086 | 0.6946 | 0.0244 |
| SK-BR-3 | JW-7-24-1 | 0.37 | uM | LJP6 | 0.7423 | 0.0097 | 0.5913 | 0.0273 |
| SK-BR-3 | JW-7-24-1 | 1.11 | uM | LJP6 | 0.6617 | 0.0201 | 0.4569 | 0.0221 |
| SK-BR-3 | JW-7-24-1 | 3.33 | uM | LJP6 | 0.5543 | 0.0225 | 0.2731 | 0.0237 |
| SK-BR-3 | JW-7-24-1 | 10 | uM | LJP6 | 0.2910 | 0.0033 | -0.2244 | 0.0796 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP5 | 1.0137 | 0.0163 | 1.0180 | 0.0214 |